Cargando…

Construction of a Redox-Related Prognostic Model with Predictive Value in Survival and Therapeutic Response for Patients with Lung Adenocarcinoma

BACKGROUND: Lung adenocarcinoma (LUAD) represents the most common histological subtype of lung cancer. Redox plays a significant role in oncogenesis and antitumor immunity. In this study, we aimed to investigate the prognostic redox-associated genes and construct a redox-based prognostic signature f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiao, Lingyan, Li, Qian, Huang, Yongbiao, Fan, Zhijie, Ma, Li, Liu, Bo, Yuan, Xianglin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896929/ https://www.ncbi.nlm.nih.gov/pubmed/35251577 http://dx.doi.org/10.1155/2022/7651758

Ejemplares similares

Integrative Analysis Constructs an Extracellular Matrix-Associated Gene Signature for the Prediction of Survival and Tumor Immunity in Lung Adenocarcinoma
por: Xiao, Lingyan, et al.
Publicado: (2022)

Identification of a prognostic classifier based on EMT-related lncRNAs and the function of LINC01138 in tumor progression for lung adenocarcinoma
por: Xiao, Lingyan, et al.
Publicado: (2022)

Characterization of molecular subtypes based on chromatin regulators and identification of the role of NPAS2 in lung adenocarcinoma
por: Huang, Yongbiao, et al.
Publicado: (2023)

Exploring the Prognostic Value, Immune Implication and Biological Function of H2AFY Gene in Hepatocellular Carcinoma
por: Huang, Yongbiao, et al.
Publicado: (2021)

A Novel Prognostic Signature for Survival Prediction and Immune Implication Based on SARS-CoV-2–Related Genes in Kidney Renal Clear Cell Carcinoma
por: Huang, Yongbiao, et al.
Publicado: (2022)

Characterization of the SARS-CoV-2 co-receptor NRP1 expression profiles in healthy people and cancer patients: Implication for susceptibility to COVID-19 disease and potential therapeutic strategy
por: Huang, Yongbiao, et al.
Publicado: (2022)

The RIPK family: expression profile and prognostic value in lung adenocarcinoma
por: Li, Guo, et al.
Publicado: (2022)

Constructing an APOBEC-related gene signature with predictive value in the overall survival and therapeutic sensitivity in lung adenocarcinoma
por: Luo, Yu, et al.
Publicado: (2023)

Comprehensive Pan-Cancer Analyses of Immunogenic Cell Death as a Biomarker in Predicting Prognosis and Therapeutic Response
por: Wang, Yuan, et al.
Publicado: (2022)

Redox-associated messenger RNAs identify novel prognostic values and influence the tumor immune microenvironment of lung adenocarcinoma
por: Zhao, Chen, et al.
Publicado: (2023)

Systematic construction and validation of an immune prognostic model for lung adenocarcinoma
por: Luo, Chenghan, et al.
Publicado: (2019)

ALKBH1-8 and FTO: Potential Therapeutic Targets and Prognostic Biomarkers in Lung Adenocarcinoma Pathogenesis
por: Wu, Geting, et al.
Publicado: (2021)

The prognostic and predictive value of solid subtype in invasive lung adenocarcinoma
por: Zhang, Yang, et al.
Publicado: (2014)

Comprehensive and Integrative Analysis of Two Novel SARS-CoV-2 Entry Associated Proteases CTSB and CTSL in Healthy Individuals and Cancer Patients
por: Huang, Yongbiao, et al.
Publicado: (2022)

SGEF is a potential prognostic and therapeutic target for lung adenocarcinoma
por: Chen, Qian, et al.
Publicado: (2018)

Construction of the optimization prognostic model based on differentially expressed immune genes of lung adenocarcinoma
por: Zhai, Yang, et al.
Publicado: (2021)

Construction and validation of a novel ferroptosis-related prognostic signature for lung adenocarcinoma
por: Yang, Li, et al.
Publicado: (2023)

A Distinct Glucose Metabolism Signature of Lung Adenocarcinoma With Prognostic Value
por: Li, Ding, et al.
Publicado: (2022)

Prognostic value of cancer antigen -125 for lung adenocarcinoma patients with brain metastasis: A random survival forest prognostic model
por: Wang, Hao, et al.
Publicado: (2018)

Identification and validation of a novel redox-related lncRNA prognostic signature in lung adenocarcinoma
por: Ren, Jie, et al.
Publicado: (2021)

Prognostic value of the immune microenvironment in lung adenocarcinoma
por: Kadota, Kyuichi, et al.
Publicado: (2013)

Establishment of a Necroptosis Related Genes Signature to Predict Prognosis and Therapeutic Response in Colon Cancer
por: Wang, Yuan, et al.
Publicado: (2022)

5-mRNA-based prognostic signature of survival in lung adenocarcinoma
por: Xia, Qian-Lin, et al.
Publicado: (2023)

Identification and validation of tumor microenvironment-related genes of prognostic value in lung adenocarcinoma
por: Yuan, Jingyan, et al.
Publicado: (2020)

A Novel RNA Binding Protein-Related Prognostic Signature for Hepatocellular Carcinoma
por: Huang, Yongbiao, et al.
Publicado: (2020)

The Prognostic Value of Bone Morphogenetic Proteins and Their Receptors in Lung Adenocarcinoma
por: Meng, Wangyang, et al.
Publicado: (2021)

Identification of New Prognostic Genes and Construction of a Prognostic Model for Lung Adenocarcinoma
por: Chen, Xueping, et al.
Publicado: (2023)

Construction and validation of a novel prognostic nomogram for predicting overall survival in lung adenocarcinoma patients with different patterns of metastasis
por: Xiong, Ying, et al.
Publicado: (2023)

Construction of subtype classifiers and validation of a prognostic risk model based on hypoxia-associated lncRNAs for lung adenocarcinoma
por: Hui, Hongliang, et al.
Publicado: (2023)

Construction and validation of an angiogenesis-related lncRNA prognostic model in lung adenocarcinoma
por: Gong, Quan, et al.
Publicado: (2023)

Prognostic value and immune infiltration of the gasdermin family in lung adenocarcinoma
por: Peng, Lu-Shan, et al.
Publicado: (2022)

The value of lncRNA FENDRR and FOXF1 as a prognostic factor for survival of lung adenocarcinoma
por: Herrera-Merchan, Antonio, et al.
Publicado: (2017)

Construction and validation of a novel prognostic signature of microRNAs in lung adenocarcinoma
por: Li, Wanzhen, et al.
Publicado: (2021)

Prognostic and predictive values of CDK1 and MAD2L1 in lung adenocarcinoma
por: Shi, Yuan-Xiang, et al.
Publicado: (2016)

KIF11 Serves as an Independent Prognostic Factor and Therapeutic Target for Patients With Lung Adenocarcinoma
por: Li, Zhaodong, et al.
Publicado: (2021)

Expression Profile and Prognostic Values of CDH Family Members in Lung Adenocarcinoma
por: Li, Feng, et al.
Publicado: (2022)

Function and prognostic value of basement membrane -related genes in lung adenocarcinoma
por: Zhang, Yurong, et al.
Publicado: (2023)

Construction of a prognostic model for lung adenocarcinoma based on bioinformatics analysis of metabolic genes
por: He, Jie, et al.
Publicado: (2020)

Prognostic value of immune related genes in lung adenocarcinoma
por: Wang, Han, et al.
Publicado: (2020)

Diagnostic and prognostic value of the BEX family in lung adenocarcinoma
por: Zhang, Zhong-Hao, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_pdf4lddk3iartuq9ohv2j0f2ts